4B6J image
Entry Detail
PDB ID:
4B6J
Keywords:
Title:
Crystal structure of phosphoserine phosphatase from T. onnurineus
Biological Source:
PDB Version:
Deposition Date:
2012-08-14
Release Date:
2012-12-26
Method Details:
Experimental Method:
Resolution:
3.34 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PHOSPHOSERINE PHOSPHATASE
Chain IDs:A, B, C, D
Chain Length:201
Number of Molecules:4
Biological Source:THERMOCOCCUS ONNURINEUS NA1
Ligand Molecules
Primary Citation
Identification of a Novel Ligand Binding Site in Phosphoserine Phosphatase from the Hyperthermophilic Archaeon Thermococcus Onnurineus.
Proteins 81 819 ? (2013)
PMID: 23239422 DOI: 10.1002/PROT.24238

Abstact

Phosphoserine phosphatase (PSP) catalyzes the final and irreversible step of L-serine synthesis by hydrolyzing phosphoserine to produce L-serine and inorganic phosphate. Developing a therapeutic drug that interferes with serine production is of great interest to regulate the pathogenicity of some bacteria and control D-serine levels in neurological diseases. We determined the crystal structure of PSP from the hyperthermophilic archaeon Thermococcus onnurineus at 1.8 Å resolution, revealing an NDSB ligand bound to a novel site that is located in a fissure between the catalytic domain and the CAP module. The structure shows a half-open conformation of the CAP 1 module with a unique protruding loop of residues 150-155 that possesses a helical conformation in other structures of homologous PSPs. Activity assays indicate that the enzyme exhibits marginal PSP activity at low temperature but a sharp increase in the k(cat)/K(M) value, approximately 22 fold, when the temperature is increased. Structural and biochemical analyses suggest that the protruding loop in the active site might be an essential component for the regulation of the activity of PSP from hyperthermophilic T. onnurineus. Identification of this novel binding site distantly located from the catalytic site may be exploited for the development of effective therapeutic allosteric inhibitors against PSP activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures